In nicotinic receptors, the binding sites for acetylcholine are likely to contain negatively charged amino acid side chains that interact with the positively charged quaternary ammonium group of acetylcholine and of other potent agonists. We previously found that a 61-residue segment ofthe 8subunit contains aspartate or glutamate residues within 1 nm of cysteines in the acetylcholine binding site on the a subunit. We have now mutated, one at a time, the 12 aspartates and glutamates in this segment of the mouse muscle 8 subunit and have expressed the mutant receptors in Xenopus oocytes.
Both the concentration of acetylcholine eliciting half-maximal current (K.pp) and the K1 for the inhibition by acetylcholine of a-bungarotoxin binding were increased 100-fold by the mutation of BAsp'80 to Asn and 10-fold by the mutation of 8Glu'89 to Gln. These two residues, and their homologs in the y and e subunits, are likely to contribute to the acetylcholine binding sites.
The binding of acetylcholine (ACh) by nicotinic receptors promotes channel opening and desensitization (1) . It is axiomatic that these changes in functional state reflect changes in structure. On binding ACh, the structure ofthe binding site changes (2, 3) . Because the ACh binding sites are extracellular and the gate is close to the cytoplasmic end of the channel (4) , the local changes at the ACh binding sites are propagated to distant parts ofthe receptor. To understand the binding of ACh, the resulting local conformational changes, and the propagation of these changes, we need to identify the amino acid residues contributing to the binding of ACh and to locate these residues in the three-dimensional structure of the receptor.
Early work with affinity labels indicated that there is a readily reducible disulfide in the ACh binding site within 1 nm of the postulated negative subsite that binds the quaternary ammonium group of ACh and other potent agonists and competitive antagonists (5) . This disulfide is formed by adjacent cysteines, aCys'92 and aCys'93, on the a subunit (6, 7) . A number of other a-subunit residues, all aromatic, have also been identified by ACh-binding-site-directed labeling.
These are aTyr93 (8, 9) , aTrp149 (10) , aTyr190 (10, 11) , and aTyr198 (12) (Fig. 1) . Their involvement in ACh binding was further supported by the functional consequences of their alteration by site-directed mutagenesis (22) (23) (24) (25) . These cysteines and aromatic residues are completely conserved in all known a-subunit sequences.
Aspartate and glutamate residues, which would be the obvious candidates for the postulated negative subsite, were not among the residues identified as contributing to the ACh binding site, and it is possible that they are not required. The affinity label, acetylcholine mustard, which is capable of reacting with carboxylates, labeled only aTyr93 (9) . Others Residues in a that were previously identified (see text) as contributing to the ACh binding site are marked with $. The mutations in 8 reported here are shown below the wild-type residues. In the a sequence, the large type represents residues that are identical in the aligned sequences of human, bovine, and Torpedo (13) , mouse (14) , and Xenopus (15) a subunits. In the ,B sequence, the large type represents residues identical in human (16) , mouse (17) , Torpedo (13) , and bovine (13) , subunits. In the yand 8 sequences, large type represents residues that are identical in human (13) , bovine (13) be bound by the electron-rich aromatic rings of tyrosine, tryptophan, and phenylalanine (26) or by ionized tyrosine phenolate side chains (8) .
There are, however, aspartates or glutamates in the receptor close enough to aCys192/Cys193 to contribute to the binding of ACh. Using a crosslinker that reacts specifically with sulfhydryls at one end and with carboxyl groups at the other end, we found in Torpedo ACh receptor that there are aspartate or glutamate residues on the 8 subunit within 0.9 nm of aCys192 and aCys193 (27 ACh-induced currents were recorded with a two-electrode voltage clamp at a holding potential of -40 mV. Electrodes were filled with 3 M KCI and had a resistance of <2 Mfl. The oocytes were held in a narrow trough and perfused at 5 ml/min (velocity, =4 cm/s) with Ca-free Ringers solution (115 mM NaCl/2.5 mM KCI/1.8 mM MgC92/0.001 mM atropine/10 mM Hepes, pH 7.5 with NaOH), in which all reagents were applied.
Oocyte membranes were prepared by homogenizing 100-200 injected oocytes in a Dounce homogenizer in 10-20 ml of ice-cold homogenization buffer (83 mM NaCl/i mM MgC92/10 mM Hepes/5 mM EDTA/5 mM EGTA/1 mM phenylmethylsulfonyl fluoride, pH 7.9) (33). Homogenates were centrifuged for 10 min at 800 x g, the supernatants were saved, and the pellets were suspended in buffer and pelleted. The combined supernatants (-42 ml) were divided, and each half was layered over 4 ml of 15% (wt/vol) sucrose and centrifuged at 4°C in a Beckman Ti 50.2 rotor at 50,000 rpm for 1.2 hr. The pellets were suspended in NP50 buffer (50 mM NaCl/10 mM sodium phosphate/i mM EDTA, pH 7.1) at 5 p1 per oocyte and stored in liquid nitrogen. Protein was assayed using bovine serum albumin as a standard (34). The final membrane suspension contained =2.6 ,ug of protein per p1. The yield was =10 fmol of toxin binding sites and 13 ,g of protein per oocyte.
The affinity for 1251-labeled a-bungarotoxin (125I-labeled toxin) was determined by diluting 25-50 p1 of membrane suspension to 400 p1 with NP50 containing 0.2% Triton X-100, mixing with 1251-labeled toxin (at seven concentrations from 0.03 nM to 3 nM), and holding at 18°C overnight. The samples were then diluted with 5 ml of ice-cold wash buffer (0.2% Triton X-100/10 mM NaCl/10 mM sodium phosphate, pH 7.4), filtered through two DE81 filters, and washed three times. The amount of 1251-labeled toxin on the filters was determined by liquid scintillation counting. Nonspecific binding was determined in the presence of 1 ,uM unlabeled a-bungarotoxin.
The equilibrium dissociation constant for ACh was determined from its inhibition of 125I-labeled toxin binding. (Fig. 1) . We expressed the mutant 8 subunit with wild-type subunits, either a and B or a, 8, and y. For each combination, we recorded the-ACh-induced current at five to seven ACh concentrations (Fig. 2) (Fig. 3 and were wild type (circles) or the mutants E186Q (squares), E189Q (triangles), or D18ON (diamonds). The quantity of toxin specifically bound at each ACh concentration was divided by the quantity specifically bound in the absence of ACh. Each curve is from a single experiment, and each point is the mean of triplicate determinations. The curves were fitted to the data as in Table 2. consistent with effects on the local interactions of ACh with its binding site. Also, comparison of the magnitude of the effects of the mutation 6D180N (100-fold) and the magnitude (=z0) of the gating isomerization constant (36, 41) suggests that the mutation 6D180N does significantly affect the local interactions of ACh. Nevertheless, an effect on the local interactions at the binding site does not prove that the mutated residue is in the site. The location of 6Asp'N and/or BGlu'89 within the binding site is supported by the finding that they are among 12 carboxylate residues in aa 8164-224, one or more of which is within 0.9 nm of aCys192/Cys'93 (27) .
The receptor has two nonidentical ACh binding sites (42-44). In the native receptor, with composition a213yS (45), one site is formed between the first a subunit and the 8 subunit, and the other site is formed between the second a subunit and the y subunit (39, 40, 46) . Furthermore, E substitutes for y in adult muscle ACh receptor (47) and also must form an ACh binding site with a. In aa 8164-224, only three carboxylate residues, 8Asp'8o, SGlu186, and 8Glu189, are conserved among all aligned segments of 8, y, and e subunits (Fig. 1) . The pattern of conservation of 8Asp'80 and 8Glu189 is consistent with their role in the ACh binding site formed between a and 8 and with the identical roles of these residues in 'y, 8 , and e. In contrast, in all the aligned (3-subunit sequences, histidine or asparagine aligns with 8Asp180 and glutamine aligns with 6Glu189 (Fig. 1) . The combination of a and (3 forms an ACh binding site poorly (39, 40, 48) . This could be due to the absence of residues in ,B corresponding to 8Asp'N and 0Glul89 and/or to the poor assembly of a and (3 in the absence of other subunits. 8Asp'80 and 6Glu189 are conserved in a, but muscle-type a does not form a homooligomer and does not form an ACh binding site (40, 49) .
In a speculative model of the ACh binding sites, we place one site between a and 8 and another between a and y (Fig.  4) . The residues that have been identified as possible contributors to ACh binding (aTyr93, aTrp149, aTyr1i9, aCys192, aCys193, and aTyr'98; 6Asp180, and BGlu189; and the aligned yAsp174 and yGlu183) are arrayed around the binding sites.
The residues aligned ( Fig. 1 ) with these binding-site residues in all subunits are also displayed. The location of residues is constrained by the quasi-fivefold symmetry of the subunits around the channel axis (50), by the order of the subunits 'ysubunits. Around the rectangles are all the residues implicated in the binding of ACh. All residues are from the mouse muscle sequences (Fig. 1) . Residues that are likely to contribute to the negative subsites, BAsp180 and BGlu189 or yAsp174 and '0Glu183, are shown in reverse contrast, as are the aligned residues in the other subunits. By symmetry, all these residues will be on the same (clockwise) side of their subunits. The residues in a that contribute to the binding site (aTyr93, aTrpl49, aTyr190, aCys'92, aCys193, and aTyr'9) and the aligned residues in the other subunits are at the counterclockwise side of their subunits. ACh is shown bound to the a-8 site, which is contracted compared to the unliganded a-ysite. The contraction ofthe site across the subunit-subunit interface is postulated to shift the one subunit relative to the other. This structural change is transmitted across the membrane to the channel gate.
around the channel (51), and by the similar tertiary structures of the subunits (52). Corresponding residues in the aligned sequences of the subunits (Fig. 1 ) must occupy nearly identical positions in the folded structures of each of the subunits and must be superimposable by a multiple of a 720 rotation around the channel axis (Fig. 4) . In keeping with fivefold symmetry, 8Asp'8O and 8Glu189 are shown on the clockwise side of 8, and their homologs, 'yAsp174 and yGlu183, are shown on the clockwise side of 'y. Likewise, the aligned residues in a and ,B are shown on the clockwise side of these subunits. (Residues on the clockwise side of each subunit are shown in reverse contrast.) Conversely, aTyr93, aTrp'49, aTyr190, aCys'92, aCys193, and aTyr198 are on the counterclockwise side of a. These residues can participate in the binding ofACh only ifthey are at the same surface of a-i.e., the surface that forms an interface with y or 6. By symmetry and the similar tertiary structure of the subunits, the residues in (3, 'y, and 8 that align with the binding-site residues in a are on the counterclockwise sides of these subunits. The sets of residues at the three-subunit interfaces that do not form ACh binding sites are quite different from the sets ofresidues at the a-8 and a-y interfaces that do form binding sites (Fig. 4) .
Because of the symmetry and similar tertiary structure of the subunits, residues in two subunits that are aligned in the sequences cannot be juxtaposed at the same interface between the subunits. For example, 6Asp214 is aligned with a residue in a 2 residues away from aTyr198 ( Fig. 1) , and therefore, 6Asp214 and aTyr198 cannot be at the same subunitsubunit interface. 6Asp214 cannot be in the ACh binding site if aTyr198 is there, further supporting our conclusion above that the mutation of 6Asp214 has a nonlocal effect on binding.
Proc. Natl. Acad. Sci. USA 90 (1993) 6289 Conversely, 8Glu189 is aligned with a residue in a that is 15 residues away from aTyr190 (Fig. 1) . Fifteen residents could span from one side of a subunit to the other (Fig. 4) . (The diameter of the receptor is about 8 nm, and the distance across a subunit midway between the channel and the outer circumference is -2.5 nm.) Therefore, 8Glu189 and aTyr'90 could be on different sides of their subunits and juxtaposed at the interface between the subunits; these residues could contribute to the same binding site (Fig. 4) .
As in this model of the ACh binding sites, the binding site for the quaternary ammonium group of phosphocholine in an anti-phosphocholine antibody is formed by aspartate, glutamate, and aromatic residues (53, 54). In the antibody, as in the receptor, the binding site is formed by residues from two polypeptide chains. Furthermore, the binding of ACh at the catalytic site of acetylcholinesterase likely involves interaction with aromatic residues (55) and with at least one glutamate residue (56).
Previously, it was inferred that ACh and other agonists bridge the binding site, from the negative subsite, which binds the quaternary ammonium group, to the region around the disulfide, which binds the acetyl group, promoting a decrease in the distance between these two ends of the binding site (ref. 5 and Fig. 4) . Because the disulfide is on the a subunit (6, 7, 57) and SAsp180 and 6Glu'89, which we hypothesize contribute to the negative subsite, are on a neighboring subunit, this contraction of the binding site could be immediately translated into a movement of one subunit relative to another. This movement of the subunits could be readily propagated to the channel gate (see ref. 50), which is close to the cytoplasmic side of the membrane (4).
